Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Clin Pharmacol Ther. 2013 Jul;94(1):95-112. doi: 10.1038/clpt.2013.81. Epub 2013 Apr 10.
This white paper addresses current approaches and knowledge gaps concerning methods to assess the role of transport proteins in drug/metabolite disposition in humans. The discussion focuses on in vitro tools to address key questions in drug development, including vesicle- and cell-based systems. How these methods can be used to assess the liability of compounds for transporter-based drug-drug interactions (DDIs) in vivo is also explored. Existing challenges and approaches to examine the involvement of transporters in drug disposition are discussed.
本白皮书探讨了当前评估转运蛋白在人体药物/代谢物处置中作用的方法和知识缺口。讨论重点是解决药物开发中的关键问题的体外工具,包括囊泡和细胞系统。还探讨了如何使用这些方法来评估化合物在体内基于转运体的药物相互作用(DDI)的风险。讨论了现有的挑战和检查转运体在药物处置中参与的方法。